Introduction
============

This Guideline aims to provide a framework for performing an adult transthoracic echocardiogram (TTE) and replaces the previous minimum datasets published. This current Guideline differs from the 2005 dataset in outlining the views and measures recommended in a fully comprehensive TTE, and in addition recognises that such studies may not be performed in all circumstances. The layout proposes a recommended sequence on how to perform a comprehensive TTE.

'Minimum requirements' are depicted in bold text and identify the views and measurements that should be performed in all subjects being scanned for the first time 'recommendations' are depicted in italics and together with the minimum requirements form the basis of a comprehensive examination. Wherever possible, a comprehensive study comprising all the views and measurements in this Guideline outlined in black italics and bold font text should be performed, provided the views and measurements can be obtained reliably. It is understood that not all the measurements in the minimum requirements dataset will be performed in all follow-up studies. It is also understood that not all measurements in the minimum requirements will be performed in focused or target studies, for example check pericardial effusion.

Both minimum requirements and recommendations may only be sufficient when the echocardiographic study is entirely normal. If abnormalities are detected, additional views may be required to supplement those outlined in the dataset.

The layout has been altered to provide a visual example of the ideal image that should be acquired in each acoustic window. This is supported by text that follows a standard layout -- the acoustic window and transducer position in the first column, followed by the modality to be used, measurements to be made at that location and an explanation if additional information is deemed necessary.

A standard adult transthoracic echocardiogram
=============================================

1. Benefits and general principles
----------------------------------

A standardised approach to performing an echocardiogram is extremely important not only to ensure that pathology is not missed but to facilitate comparison between studies.

1.1. The intended benefits of this Guideline are:

To support cardiologists and echocardiographers to develop local protocols and quality control programmes for an adult transthoracic study. These minimum requirements and recommendations provide a template against which studies in any department should be audited.To promote quality by defining a \'minimum dataset\' of descriptive terms and measurements.To promote quality by defining a recommended dataset of descriptive terms and measurements that departments should work toward obtaining in all studies.To facilitate accurate comparison of serial echocardiograms performed in patients at the same or different sites.To facilitate the transition to digital echocardiography acquisition and reporting systems that use database (software) architecture.

1.2. There is broad agreement regarding the standard views and recordings essential in an echocardiographic examination. There is, however, no evidence-base and these recommendations and requirements represent a consensus view on the components of a complete TTE study.

1.3. It is expected that a standard echocardiogram following at least these minimum requirements will be performed in all adults when an echocardiogram is requested. This type of study is expected to make up the majority of those performed within any department, whether in the community or in hospital.

It is recognised that focused studies may be appropriate in some circumstances agreed locally. Focused TTE can either mean focusing on major abnormalities predominantly in an urgent clinical situation, e.g. pericardial effusion, or focusing on a particular aspect of the heart, e.g. longitudinal monitoring of left ventricular function. The skill level required for such studies is very high and it is expected that the patient will previously have had a full-standard TTE before monitoring commences or after an emergency assessment has been completed. Such studies should be clearly identified as focused studies and are not covered by this Guideline.

1.4. When the condition or acoustic windows of the patient prevent the acquisition of one or more components of the minimum dataset, or when measurements result in misleading information (e.g. off-axis measurements) this should be stated.

It is recommended that any study is accompanied by a statement regarding the image quality achieved: good/fair/poor.

1.5. Unless the physical condition of the patient prevents transfer, all TTEs should be performed in a suitable environment, with optimal facilities to obtain the highest quality ultrasound images, including lighting, space and imaging couches, whilst guaranteeing patient privacy. These facilities demand -- except in exceptional circumstances -- that echocardiography is delivered in an appropriately equipped department that satisfies the requirements of the BSE Departmental Accreditation process. This ensures optimum conditions for a detailed study, reduces the risk of musculoskeletal disorders for echocardiographers (<http://www.hse.gov.uk/healthservices/management-of-musculoskeletal-disorders-in-sonography-work.pdf>), and may reduce the risk of hospital-acquired infection. When portable echocardiography has to be performed at the bedside, the requirements of the minimum dataset must be met.

2. Identifying information
--------------------------

The images acquired should be clearly labelled with patient identifiers, including the following:

Patient name.A second unique identifier such as hospital number or date of birth.Identification of the operator, e.g. initials.

3. Electocardiogram (ECG)
-------------------------

An ECG should be attached ensuring good tracings to facilitate the acquisition of complete digital loops. Loops should be examined and adjusted accordingly in order to ensure a clear representation of the image acquired.

4. Height/weight/haemodynamic variables
---------------------------------------

Qualitative and quantitative evaluation of chamber size and function is a major component of every echocardiographic examination. Chamber dimensions may be influenced by age, gender and body size. Therefore, consideration should be given to the use of referenced ranges indexed to height or body surface area. In addition, velocities measured using Doppler should take account of pulse rate and blood pressure. No recommendation is made to the routine use of indexed measurements, but facilities should be available to sonographers to measure height, weight, pulse rate and blood pressure at the time of an echocardiogram.

5. Duration
-----------

The average time required for performance and reporting of a fully comprehensive TTE following these recommendations is considered to be 40--45 min, although it is understood that some studies may take longer whilst others may take less time. The time taken for a standard TTE should include time to complete a report, and should also take into account the time taken for patient preparation.

6. Report
---------

No standard TTE is complete until a report is released and is made available to the referring individual. The majority of studies performed in a department should be reported immediately on completion and a report available on discharge of a patient from the echocardiography facility.

It is recognised that there are times when a review of images and further consideration is required, for example when the individual performing the scan does not hold proficiency accreditation and the scan requires review before release, although this should be done as soon as possible.

7. Chaperones
-------------

A standard TTE is not considered as an intimate examination, but performance still requires patient sensitivity. Chaperones should not usually be required for standard TTE; however, for all TTE studies, patients should be offered a gown.

Echocardiography departments should send out an information leaflet with any appointment. This should include a statement that a relative or friend could accompany the patient to act as a chaperone during the study if preferred. If a friend or relative cannot attend, the leaflet should include an offer to provide a chaperone if requested by the patient. This leaflet should either offer a chaperone by mutual arrangement or, if facilities and personnel allow, a chaperone to be provided on request when the patient arrives.

A notice should be displayed in the Echocardiography department where it can be seen by patients repeating the offer of a chaperone if requested. In practice, it is expected that the majority of patients would not need or have a chaperone.

The minimum dataset
===================

The minimum dataset and recommended sequence for a standard TTE is shown in [Table 1](#tbl2){ref-type="table"}. The minimum requirements are depicted in bold text and recommendations in italics. The minimum requirements are also summarised in [Appendix 1](#tbl3){ref-type="table"}. Table 1Minimum dataset for transthoracic echocardiography. Minimum requirements are depicted in bold text and identify the views and measurements that should be performed in all subjects being scanned for the first time provided that they can be obtained reliably. However wherever possible a comprehensive study should be performed. Recommendations are depicted in italics and together with the minimum requirements form the basis of a comprehensive examination**View** (modality)**MeasurementExplanatory noteImage**PLAX (2D)**LVIDd/s, IVSd, LVPWd (either 2D or M mode measurement)**\
\
**LA size (end ventricular systole) (either 2D or M mode measurement)LV cavity size, wall thickness, radial function**\
\
**LA appearance**\
\
**MV leaflet and annulus appearance and function: thickness, mobility, calcification, commissural fusion, sub-valve apparatus**![](echo-02-G9-i001.jpg)PLAX (2D)**AV/LVOT appearance and function**![](echo-02-G9-i002.jpg)PLAX (2D)*Proximal RVOTd*![](echo-02-G9-i003.jpg)PLAX (2D)**Sinus of Valsalva (either 2D or M mode measurement, inner edge to inner edge at widest diameter)**\
\
*Annulus, ST junction, proximal ascending aorta (inner edge to inner edge, at widest diameter)***Aortic root -- appearance and function**![](echo-02-G9-i004.jpg)PLAX (2D)*LVOT for AV area/SVol in mid systoleApproximately same location as the PW sample volume in the A5C view (measured in the LVOT up to 1 cm from the annulus)*![](echo-02-G9-i005.jpg)PLAX (2D)*Proximal ascending aorta at widest diameter (inner edge to inner edge)Tilted superiorly to demonstrate mid ascending aorta*![](echo-02-G9-i006.jpg)PLAX (MM)*Aortic root (end diastole)*\
\
*Maximum LA size (end systole), providing 2D image is on axisAortic valve at leaflet tips*![](echo-02-G9-i007.jpg)PLAX (MM)**LVIDd/s, IVSd, LVPWd (either/or 2D measurement)Left ventricle, just distal to MV leaflet tips**![](echo-02-G9-i008.jpg)PLAX (CFM)**Look for abnormal colour flow**\
\
**Adjust Nyquist limit: 50--60 cm/s**![](echo-02-G9-i009.jpg)PLAX RV inflow (2D)**RV cavity size and function**\
\
**RA, IVC, +/− coronary sinus**\
\
**TV -- appearance and function**![](echo-02-G9-i010.jpg)PLAX RV inflow (CFM)**TV inflow, TR**![](echo-02-G9-i011.jpg)PLAX RV inflow (CW)**TR V** ~**max**~**If good alignment with jet**![](echo-02-G9-i012.jpg)PLAX RV outflow (2D)*Distal RVOTRVOT, PV, main PA, LPA*![](echo-02-G9-i013.jpg)PLAX RV outflow (CFM)*RVOT, PA, PS, PR*\
\
*Optional to PSAX*![](echo-02-G9-i014.jpg)PLAX RV outflow (PW)*Optional to PSAX*PLAX RV outflow (CW)*Optional to PSAX*PSAX outflow (2D)*Proximal RVOT diameter***RVOT (function)**\
\
**AV -- appearance and function**\
\
**LA/atrial septum**\
\
**TV -- appearance and function**![](echo-02-G9-i015.jpg)PSAX outflow (2D)*PV annulus, main PA***PV, main PA**![](echo-02-G9-i016.jpg)PSAX outflow (2D)*Proximal branch PA\'s*![](echo-02-G9-i017.jpg)PSAX outflow (CFM)**Ao/LA**\
\
**Atrial septum**\
\
**IVC**\
\
**TV inflow, TR**![](echo-02-G9-i018.jpg)PSAX outflow (CFM)**PA, look for abnormal colour flow**![](echo-02-G9-i019.jpg)PSAX outflow (CFM)**RVOT (PR)**![](echo-02-G9-i020.jpg)PSAX outflow (PW)*V* ~*max*~ *, V* ~*mean*~ *, VTIRVOT (just proximal to PV)*![](echo-02-G9-i021.jpg)PSAX outflow (CW)***V*** ~***max***~ ***,*** *V* ~*mean*~ *PHT***PA**\
\
**PR density and contour of signal**![](echo-02-G9-i022.jpg)PSAX outflow (CW)*PR V* ~*max*~ *(end diastolic PA pressure)End diastole*![](echo-02-G9-i023.jpg)PSAX outflow (CW)*PR V* ~*max*~ *(mean diastolic PA pressureEarly diastole*![](echo-02-G9-i024.jpg)PSAX Base (2D)**MV leaflet and annulus:**\
**-- appearance and function**\
**-- thickness, mobility, calcification, commissural fusion, sub-valve apparatus**![](echo-02-G9-i025.jpg)PSAX mid (2D)**Sweep beam from base to apex**\
\
**Radial systolic function/regional wall motion abnormalities**\
\
**Integrity of ventricular septum**![](echo-02-G9-i026.jpg)PSAX (CFM)**Sweep beam from base to apex**\
\
**Integrity of ventricular septum**![](echo-02-G9-i027.jpg)PSAX (CFM)**VSD\'s (congenital/post infarct)**![](echo-02-G9-i028.jpg)A4C (2D)**LV cavity size, wall thickness (Inferoseptum, anterolateral)**\
\
**Longitudinal and radial function:**\
\
**RWMA\'s (inferoseptal and anterolateral)**\
\
**MV/TV appearance and function**\
\
**Atrial septal mobility**![](echo-02-G9-i029.jpg)A4C (2D)**Area/volume** ***(should not be done if images sub optimal)*LV end diastolic area/volume (BSA indexed)**. *Consider 3D volumes, unless images are suboptimal*\
\
*Consider LV opacification contrast if poor image quality*![](echo-02-G9-i030.jpg)A4C (2D)**LV end systolic area/volume (BSA indexed).** *Consider 3D volumes, unless images are suboptimal*\
\
*Consider LV opacification contrast if poor image quality*![](echo-02-G9-i031.jpg)A4C (2D)**LA volumeLA size (measured at end ventricular systole and BSA indexed)**![](echo-02-G9-i032.jpg)A4C (MM)**TAPSE**\
*MAPSE***TV annulus**\
\
*MV annulus*![](echo-02-G9-i033.jpg)A4C (CFM)**MV inflow, look for abnormal flow**![](echo-02-G9-i034.jpg)A4C (CFM)*RLPV either/or RUPV*\
\
*LUPV, LLPV can also be imaged*![](echo-02-G9-i035.jpg)A4C (PW)**E V** ~**max**~ **, A V** ~**max**~**LV inflow (MV tips)**![](echo-02-G9-i036.jpg)A4C (PW)*Deceleration time*![](echo-02-G9-i037.jpg)A4C (PW)*PV* ~*S*~ */PV* ~*D*~\
\
*PVa*\
\
*a* ~*dur*~ *−A* ~*dur*~*Right lower pulmonary vein*![](echo-02-G9-i038.jpg)A4C (CW)**MR (shape and density of signal)**![](echo-02-G9-i039.jpg)A4C (TDI)**e\'**\
\
*a\', s\'***Septal and/or lateral LV**\
\
*Lateral RV*![](echo-02-G9-i040.jpg)A5C (2D)**LV cavity size, wall thickness, function**\
\
**LVOT**\
\
**AV appearance and function**![](echo-02-G9-i041.jpg)A5C (CFM)**LVOT, look for abnormal colour flow**![](echo-02-G9-i042.jpg)A5C (PW)*V* ~*max*~\
\
*VTI (stroke volume, cardiac output)***LVOT**![](echo-02-G9-i043.jpg)A5C (CW)![](echo-02-G9-i044.jpg)A2C (2D)**LV cavity size, wall thickness: function (anterior, inferior)**![](echo-02-G9-i045.jpg)A2C (2D)**LV area/volumeLV end diastolic area/volume**\
\
*Consider 3D volumes, unless images are suboptimal*\
\
*Consider LV opacification contrast if poor image quality*![](echo-02-G9-i046.jpg)A2C (2D)**LV end systolic area/volume**\
\
*Consider 3D volumes, unless images are suboptimal*\
\
*Consider LV opacification contrast if poor image quality*![](echo-02-G9-i047.jpg)A2C (2D)**LA area/volume (measure at end ventricular systole)**\
\
**Modified Simpsons or area length methodLA size**![](echo-02-G9-i048.jpg)A2C (CFM)**LV inflow, look for abnormal colour flow**![](echo-02-G9-i049.jpg)A2C (PW)*E, A, DT if not reliable from A4CLV inflow (MV tips)*A2C (CW)*V* ~*max*~ *, V* ~*mean*~ *if not reliable from A4C*A3C (2D)**LV cavity size, wall thickness:**\
\
**function (anteroseptal and inferolateral)**\
\
**AV/LVOT appearance and function**![](echo-02-G9-i050.jpg)A3C (CFM)**LVOT, LV inflow, look for abnormal colour flow**![](echo-02-G9-i051.jpg)ALAX (PW)*E, A, DT,VTI* *if not reliable from A5CLV inflow (MV tips)*\
*LVOT*A3C (CW)*V* ~*max*~ *, V* ~*mean*~\
\
*V* ~*max*~ *, V* ~*mean*~*LV inflow*\
\
*LVOT*Modified A4C (2D)**RVID base (d)**\
\
*Mid RV diameter*\
\
*RV length (base to apex)*\
\
*RA area***RV cavity size and function**\
\
\
\
\
\
**RA size**![](echo-02-G9-i052.jpg)Modified A4C (CFM)**TV inflow, TR**![](echo-02-G9-i053.jpg)Modified A4C (PW)*E V* ~*max*~*RV inflow (TV leaflet tips)*![](echo-02-G9-i054.jpg)Modified A4C (CW)**V** ~**max**~ **(RV systolic pressure, PAP)TR**![](echo-02-G9-i055.jpg)SC4C (2D)**Four chamber structures, atrial septum**![](echo-02-G9-i056.jpg)SC4C (CFM)**Atrial septum**\
\
**Consider reducing Nyquist limit to detect low velocity flow**![](echo-02-G9-i057.jpg)SCSAX (2D)**IVC, hepatic vein (modified view)**![](echo-02-G9-i058.jpg)SCSAX (MM)**Size and respiratory variation ('sniff')IVC just proximal to hepatic vein**![](echo-02-G9-i059.jpg)SCSAX (2D)*SAX structures*\
\
*Atrial septum, TV, RVOT, PV, PA\'s*![](echo-02-G9-i060.jpg)SCSAX (2D)*Abdominal aorta (modified view)*![](echo-02-G9-i061.jpg)SCSAX (PW)*Hepatic veins*![](echo-02-G9-i062.jpg)SCSAX (PW)*Abdominal aorta*![](echo-02-G9-i063.jpg)SSN (2D)**Arch**![](echo-02-G9-i064.jpg)SSN (CFM)**Arch, RPA, look for abnormal colour flow**![](echo-02-G9-i065.jpg)SSN (CW)*V* ~*max*~**Descending aorta with imaging probe, if good alignment with jet**\
\
**Descending aorta with non imaging probe, if poor jet alignment with imaging probe**![](echo-02-G9-i066.jpg) Appendix 1Minimum dataset measurements1. Views to be obtained: PLAXParasternal long axis PLAXTilted RV inflow PSAXParasternal short axis: base, mid, apex A4CApical four chamberModified A4C for RV A2CApical two chamber A5CApical five chamber SCSubcostal SSNSuprasternal2. Recorded and measured where appropriate LVIDd/sLeft ventricular internal dimension in diastole and systole IVSdInterventricular septal width in diastole LVPWdLeft ventricular posterior wall width in diastole LALeft atrial dimension in PLAX SinusSinus of valsalva TR V~max~Tricuspid regurgitation maximal velocity LVEDvol d/sLeft ventricular end-diastolic and systolic volume (biplane/3D) LVEFLeft ventricular ejection fraction LA volumeLeft atrial volume at end-ventricular systole (area-length/biplane) TAPSETricuspid annular plane systolic excursion Mitral E/AMitral valve maximal velocity early and atrial filling e\'Lateral and/or septal early myocardial relaxation velocity AV V~max~Maximal aortic velocity on CW RV baseRight ventricular basal dimension in diastole IVC dimensionEstimation of RA pressure

[](#tbl1){ref-type="table"} AbbreviationsViews A2CApical two chamber A4CApical four chamber A5CApical five chamber A3CApical long axis or apical three chamber PLAXParasternal long axis PSAXParasternal short axis SCSubcostal SSNSuprasternalModality CFMColour flow Doppler CWContinuous wave Doppler PWPulse wave Doppler TDITissue Doppler imagingMeasurement and explanatory text AoAorta AVAortic valve BSABody surface area DTDeceleration time IVCInferior vena cava IVSdInterventricular septal width in diastole LALeft atrium LLPVLeft lower pulmonary vein LPALeft pulmonary artery LUPVLeft upper pulmonary vein LVLeft ventricle LVIDd/sLeft ventricular internal dimension in diastole and systole LVOTLeft ventricular outflow tract LVPWdLeft ventricular posterior wall width in diastole MAPSEMitral annular plane systolic excursion MVMitral valve PAPulmonary artery PAPPulmonary artery pressure PHTPressure half-time PRPulmonary regurgitation PSPulmonary stenosis PVPulmonary valve RARight atrium RLPVRight lower pulmonary vein RUPVRight upper pulmonary vein RVRight ventricle RVIDdRight ventricular cavity diameter in diastole RWMARegional wall motion abnormality RVOTRight ventricular outflow tract RVOTdRight ventricular outflow tract dimension STJSinotubular junction SVolStroke volume TAPSETricuspid annular plane systolic excursion TRTricuspid regurgitation TVTricuspid valve V~max~Maximum velocity VSDVentricular septal defect VTIVelocity time integral
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